Biotech

All Articles

A deeper take a look at Fierce Biotech's Intense 15

.In this particular full week's incident of "The Top Pipe," our team are actually diving in to Inten...

Lilly faces stage 2 failure of tau-targeting med

.The confetti is still flying from Eli Lilly's celebration celebrating the commendation of Alzheimer...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of substantial leadership hirings, firings and a...

Lykos will inquire FDA to reevaluate its own decision complying with denial of MDMA treatment for trauma

.Complying with a poor revealing for Lykos Therapeutics' MDMA candidate for trauma at a latest FDA a...

AN 2 fifty percents headcount, quits stage 3 trial after records dissatisfy

.AN2 Rehabs is actually reconsidering its company in response to poor midphase records, vowing to gi...

Merck pays out $700M for bispecific, snooping autoimmune opening as well as possibility to test Amgen in cancer

.Merck &amp Co. is actually paying for $700 million upfront to challenge Amgen in a blood cancer cel...

Gilead spends J&ampJ $320M to exit licensing package for seladelpar

.With Gilead Sciences about to an FDA choice for its liver illness drug seladelpar, the business has...

' All palms on deck' at Lilly as peers target being overweight market

.Chief executive officer David Ricks can easily observe the business setting up outdoors tents at ba...

Entero giving up staff, moving out of workplace and also stopping briefly R&ampD

.Mattress Liquidators has actually turned Entero Therapies white colored as a sheet. The creditor go...

Exelixis drops ADC after determining it's no match for Tivdak

.Exelixis is actually surrendering on its tissue factor (TF)- targeting antibody-drug conjugate afte...